All In MedTech

FDA Clearance Tracker · P240045

Optimum Infinite (tisilfocon A) Orthokeratology Lenses II

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Feb 10, 2026 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Feb 10, 2026

Approved

Time to decision

420 days

Received Dec 17, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P240045
Device name
Optimum Infinite (tisilfocon A) Orthokeratology Lenses II
Applicant location
Saffron Walden
Received
Dec 17, 2024
Decided
Feb 10, 2026
Decision
Approved

Device type

Device class
Class III
Regulation
21 CFR 886.5916
Specialty
Ophthalmology

Every decision under product code NUU

FDA's approval statement

As written in FDA's record.

Approval for Optimum Infinite (tisilfocon A) Ortho-k Lenses, Optimum Infinite (tisilfocon A) Orthokeratology Lenses II.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NUU. The earliest in FDA's data is P870024-S043, decided Jun 13, 2002.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Contamac, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.